Search

Your search keyword '"de Knegt, Robert J"' showing total 711 results

Search Constraints

Start Over You searched for: Author "de Knegt, Robert J" Remove constraint Author: "de Knegt, Robert J"
711 results on '"de Knegt, Robert J"'

Search Results

3. Metabolic Dysfunction–Associated Fibrosis 5 (MAF-5) Score Predicts Liver Fibrosis Risk and Outcome in the General Population With Metabolic Dysfunction

4. An international multidisciplinary consensus statement on MAFLD and the risk of CVD

5. The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus

6. Correction: LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries

9. Genetic analysis in European ancestry individuals identifies 517 loci associated with liver enzymes

10. Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study

15. B cell activation gene signature in blood and liver of HBeAg+ immune active chronic hepatitis B patients

16. SAT-200-YI Statin use is associated with liver fibrosis regression in the general population: a longitudinal analysis of The Rotterdam Study

17. TOP-241-YI Longitudinal changes in liver stiffness measurements in a population-based screening cohort of 5, 517 participants

20. FRI-200 Magnitude of steatotic liver disease before and after liver transplantation and the impact of immunosuppressive medication: a multidimensional study

22. SAT-462-YI The interplay between steototic liver disease and viral infections: systematic review, meta-analysis and data synthesis

26. Hepatitis C Elimination in the Netherlands (CELINE): How nationwide retrieval of lost to follow-up hepatitis C patients contributes to micro-elimination

27. LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries

29. Addition of PEG‐interferon to long‐term nucleos(t)ide analogue therapy enhances HBsAg decline and clearance in HBeAg‐negative chronic hepatitis B

33. Objectives, design and main findings until 2020 from the Rotterdam Study

35. Progression of the FIB-4 index among patients with chronic HCV infection and early liver disease

39. Epigenome-wide association meta-analysis of DNA methylation with coffee and tea consumption

43. HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies

45. Socio‐economic factors associated with loss to follow‐up among individuals with HCV: A Dutch nationwide cross‐sectional study.

46. Nonalcoholic fatty liver disease, liver fibrosis, and structural brain imaging: The Cross‐Cohort Collaboration.

47. A Fatal Outcome after Cessation of Nucleotide Analogue Therapy in a Patient with Chronic Hepatitis B: A Case Report.

48. Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study

49. Nonalcoholic fatty liver disease, liver fibrosis, and structural brain imaging: The Cross‐Cohort Collaboration

50. Effect of bariatric surgery on NAFLD/NASH: a single-centre observational prospective cohort study

Catalog

Books, media, physical & digital resources